A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes This trial is conducted in Europe. The aim of the trial is to test for bioequivalence between two formulations of insulin degludec/insulin aspart (IDegAsp) to see if the efficacy and safet...

• Pays Austria
• Organes Aucun
• Spécialités Aucune

To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent To determine the Objective Response Rate of 4 cycles of docetaxel + anthracycline (epirubicin or doxorubicine) followed by 4 cycles of docetaxel single agent. To determine the Time to Tumo...

• Pays Austria, Poland
• Organes Aucun
• Spécialités Aucune

Safety Study of the PulseRider® in Patients Undergoing Treatment for Bifurcation Intracranial Aneurysms This is a prospective multi-center, single arm, non-randomized study. It is designed to evaluate the safety of the PulseRider® in patients undergoing treatment for bifurcation intracranial...

• Pays Austria
• Organes Aucun
• Spécialités Aucune

The Relationship Between Muscle Morphology and Muscle Strength The evaluation of skeletal muscle strength in severly ill or cognitive impaired patients is an unresolved problem especially during the rehabilitation process. The aim of this study is to ...

• Pays Austria
• Organes Aucun
• Spécialités Aucune

Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL The aim of this study is to determine the maximal tolerated dose level of lenalidomide combined with fludarabine/rituximab in the therapy of patients with previously untreated CD20-positiv...

• Pays Austria
• Organes Aucun
• Spécialités Aucune

Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) The present trial investigates the long-term safety, tolerability and efficacy of bosentan in patients with inoperable CTEPH.

• Pays Australia, Austria, Belgium, Canada, Czech Republic, France, Germany, Italy, Netherlands, Poland, Spain, United Kingdom, United States
• Organes Aucun
• Spécialités Aucune

Immune Globulin Subcutaenous (Human), 20% The purpose of the study is to develop a 20% subcutaneous immunoglobulin treatment option for patients with primary immunodeficiency (PID) diseases.

• Pays Austria, Germany, Hungary, Sweden, United Kingdom
• Organes Aucun
• Spécialités Aucune

Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis The purpose of this study is to investigate the response to pioglitazone on the hepatic venous pressure gradient and peripheral vascular responsiveness to vasoconstrictors in patients with...

• Pays Austria
• Organes Aucun
• Spécialités Aucune

PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism The purpose of this study is to compare two treatments strategies to prevent further attacks in patients who have suffered an stroke or occlusion of a major artery with no obvious reason o...

• Pays Australia, Austria, Belgium, Switzerland
• Organes Aucun
• Spécialités Aucune

Kuvan® Adult Maternal Pediatric European Registry

• Pays Austria, France, Germany, Italy, Netherlands, Slovakia, Spain, Sweden
• Organes Aucun
• Spécialités Aucune